Help with addiction starts with one call.

877-922-8999
Person Person Person

Thousands of people helped nationwide.

Bergand Group - Harford County

Contact Information
1803 Harford Road, Fallston, MD, Maryland 21047
0.000
Detailed Information

The Bergand Group: Comprehensive Outpatient Addiction Treatment in Harford County

The Bergand Group is a state-certified and licensed treatment center dedicated to helping individuals overcome chemical dependency, substance abuse, and co-occurring mental health disorders. Situated in Fallston, Maryland, the Harford County office provides vital, flexible outpatient services for the greater Baltimore and Harford County areas. Their approach emphasizes individualized care, rooted in evidence-based practices designed to promote long-term recovery and significant improvements in physical, mental, and emotional well-being.

Personalized Treatment Programs

Understanding that addiction affects everyone differently, The Bergand Group offers various levels of intensity in their outpatient services. The foundation of their offerings is their Intensive Outpatient Program (IOP), which features daily three-hour sessions. These programs integrate medication management when necessary, ensuring patients receive comprehensive care. Beyond the IOP, they provide Phase II Group (Outpatient Treatment) and a range of clinical services tailored to meet diverse patient needs.

Key Services Offered

  • Intensive Outpatient Programs (IOP)
  • General and Addiction Psychiatry
  • Individual and Couples Therapy
  • DUI/DWI Educational Programs
  • Group Therapy and Psychoeducational Programs
  • Medication Management and Relapse Prevention

The facility is also equipped to provide pharmacologic therapy, including drug monitoring and prescribing, use of antagonist and blocking agents, and buprenorphine—both for detox and maintenance. This medical support is provided by on-site staff, aligning with The Bergand Group’s drug-free/abstinence philosophy as a core principle of addiction treatment. The dual-diagnosis focus, established by founders Dr. John Steinberg and Dr. Paul Giannandrea, ensures that co-occurring mental health issues are addressed alongside substance use disorders.

Accessibility and Support

The Bergand Group is committed to making treatment accessible. They accept both private insurance and Maryland Medicaid, helping to remove financial barriers to necessary care. The team believes in building strong, long-lasting relationships with patients and healthcare providers to ensure cohesive and effective treatment plans. Prospective patients or referring clinicians are encouraged to call the Harford County office directly to schedule assessments and discuss how their flexible treatment approach can best serve individual needs.

FAQs

What is the difference between IOP and standard outpatient treatment?

An Intensive Outpatient Program (IOP) requires a higher time commitment, typically involving three-hour sessions daily, whereas standard outpatient treatment often involves less frequent sessions and is suited for individuals requiring less structure or those stepping down from an IOP.

Does The Bergand Group treat co-occurring disorders?

Yes, treating co-occurring disorders (also known as dual diagnosis), which include both substance abuse and mental health issues, is a primary focus and foundational element of The Bergand Group’s comprehensive treatment approach.

What types of payment are accepted for treatment?

The Bergand Group accepts private insurance plans and Maryland Medicaid to cover the costs of their addiction treatment services.

Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm
Type of Care
Substance use treatment
Detoxification
Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting
Outpatient, Outpatient methadone/buprenorphine or naltrexone treatment, Regular outpatient treatment
Opioid Medications used in Treatment
Buprenorphine used in Treatment, Naltrexone used in Treatment
External Opioid Medications Source
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Type of Alcohol Use Disorder Treatment
Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
This facility administers/prescribes medication for alcohol use disorder
Source of Medications Used for Alcohol Use Disorder Treatment
In-network prescribing entity
Other contracted prescribing entity
No formal relationship with prescribing entity
Type of Opioid Treatment
Buprenorphine detoxification
Buprenorphine maintenance
Prescribes buprenorphine
Prescribes naltrexone
Relapse prevention with naltrexone
Accepts clients using MAT but prescribed elsewhere
Pharmacotherapies
Acamprosate (Campral®)
Disulfiram
Buprenorphine sub-dermal implant
Buprenorphine with naloxone
Buprenorphine without naloxone
Buprenorphine (extended-release, injectable)
Naltrexone (oral)
Naltrexone (extended-release, injectable)
Lofexidine
Clonidine
Medication for mental disorders
Nicotine replacement
Non-nicotine smoking/tobacco cessation
Treatment Approaches
Brief intervention
Cognitive behavioral therapy
Contingency management/motivational incentives
Motivational interviewing
Relapse prevention
Substance use disorder counseling
Trauma-related counseling
Telemedicine/telehealth therapy
12-step facilitation
Facility Operation
Private for-profit organization
License/Certification/Accreditation
State substance use treatment agency
State mental health department
State department of health
Find Help (877) 922-8999